Header image
Journals 2022
Error message
User warning: Trying to overwrite a cache redirect for "entity_view:node:945:template_managed:[languages:language_interface]=en:[theme]=imtm:[timezone]=Europe/Prague:[user.permissions]=beeceec8335b964d0ae2534050979a35617cfbed52bd079a5ed152cf5841f8f2" with one that has nothing in common, old one at address "languages:language_interface, theme, user.permissions, timezone" was pointing to "url.query_args:language_content_entity", new one points to "url.query_args:language". in Drupal\Core\Cache\VariationCache->set() (line 238 of core/lib/Drupal/Core/Cache/VariationCache.php).
HODOŇ, J., I. FRYDRYCH, Z. TRHLÍKOVÁ, J. POKORNÝ, L. BORKOVÁ, S. BENICKÁ, M. VLK, B. LIŠKOVÁ, A. KUBÍČKOVÁ, M. MEDVEDÍKOVÁ, M. PISÁR, J. ŠAREK, V. DAS, A. LIGASOVÁ, K. KOBERNA, P. DŽUBÁK, M. HAJDÚCH, M. URBAN
HORGAN, D., M. HAJDÚCH, M. VRANA, J. SODERBERG, N. HUGHES, M. OMAR, J. LAL, M. KOZARIC, F. CASCINI, V. THALER, O. SOLA-MORALES, M. ROMAO, F. DESTREBECQ, E. GROSS
ŘEHULKA, J., I. SUBTELNA, A. KRYSHCHYSHYN-DYLEVYCH, A. CHERNIIENKO, A. IVANOVA, M. MATVEIEVA, P. POLISHCHUK, S. GURSKÁ, M. HAJDÚCH, O. ZAGRIJTCHUK, P. DŽUBÁK, R. LESYK
Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitors. Archiv der Pharmazie. 2022, 355(12), e2200419, ISSN: 0365-6233, PMID: 36109178,
BLANCO, Z., E. FERNANDEZ-MOREIRA, M. MIJARES, C. CELIS, G. MARTINEZ, J. DE SANCTIS, S. GURSKÁ, P. DŽUBÁK, M. HAJDÚCH, A. MIJOBA, Y. GARCIA, X. SERRANO, N. HERRERA, J. CORREA-ABRIL, Y. PARRA, J. ANGEL, H. RAMIREZ, J. CHARRIS
SMEŠNÝ TRTKOVÁ, K., P. LUŽNÁ, D. WEISER DROZDKOVA, K. ČÍŽKOVÁ, L. JANOVSKA, J. GURSKÝ, D. PRUKOVA, I. FRYDRYCH, M. HAJDÚCH, J. MINARIK
The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression. Molecular Medicine Reports. 2022, 26(4), 321, ISSN: 1791-2997, PMID: 36043519,
SCHADICH, E., S. NYLEN, S. GURSKÁ, J. KOTULOVÁ, S. ANDRONATI, V. PAVLOVSKY, S. SOBOLEVA, P. POLISHCHUK, M. HAJDÚCH, P. DŽUBÁK
Activity of 1-aryl-4-(naphthalimidoalkyl) piperazine derivatives against Leishmania major and Leishmania mexicana. Parasitology International. 2022, 91, 102647, ISSN: 1383-5769, PMID: 35985636,